Calidi Biotherapeutics, Inc.

Calidi Biotherapeutics, Inc.verified

CLDI

Price:

$0.1536

Market Cap:

$1.13M

Calidi Biotherapeutics, Inc. is a clinical-stage biotechnology company focused on immuno-oncology, dedicated to developing advanced immunotherapies for various cancers. The company's innovative approach centers on utilizing powerful, allogeneic (donor-derived) stem cells as specialized carriers for anti-tumor agents. This technology is being advanced to address a range of oncological conditions, including aggressive brain tumors (high-grade gliomas) and other solid malignancies. Calidi's proprietary cell-based delivery systems are expertly designed to safeguard, amplify, and boost the therapeutic effects of oncolytic viruses. This strategic delivery method aims to achieve superior treatment ...[Read more]

Industry

Biotechnology

IPO Date

2021-11-01

Stock Exchange

AMEX

Ticker

CLDI

The PE Ratio as of June 2026 (TTM) for Calidi Biotherapeutics, Inc. (CLDI) is -0.04

According to Calidi Biotherapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.04. This represents a change of -88.40% compared to the average of -0.34 of the last 4 quarters.

Calidi Biotherapeutics, Inc. (CLDI) Historical PE Ratio (quarterly & annually)

How has CLDI PE Ratio performed in the past?

The mean historical PE Ratio of Calidi Biotherapeutics, Inc. over the last ten years is -78.54. The current -0.04 PE Ratio has changed -94.91% with respect to the historical average. Over the past ten years (40 quarters), CLDI's PE Ratio was at its highest in in the March 2026 quarter at -0.15. The PE Ratio was at its lowest in in the June 2021 quarter at -7001.26.

Quarterly (TTM)
Annual

Average

-78.54

Median

-2.11

Minimum

-440.67

Maximum

-0.25

Calidi Biotherapeutics, Inc. (CLDI) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Calidi Biotherapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual PE Ratio = -0.25

Minimum Annual Increase = -94.17%

Minimum Annual PE Ratio = -440.67

Quarterly (TTM)
Annual
YearPE RatioChange
2025-0.25-38.94%
2024-0.41-50.05%
2023-0.83-75.53%
2022-3.39-86.81%
2021-25.69-94.17%

Calidi Biotherapeutics, Inc. (CLDI) Average PE Ratio

How has CLDI PE Ratio performed in the past?

The current PE Ratio of Calidi Biotherapeutics, Inc. (CLDI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-0.50

5-year avg

-6.12

10-year avg

-78.54

Calidi Biotherapeutics, Inc. (CLDI) PE Ratio vs. Peers

How is CLDI’s PE Ratio compared to its peers?

Calidi Biotherapeutics, Inc.’s PE Ratio is greater than Clearmind Medicine Inc. (-0.58), greater than Can-Fite BioPharma Ltd. (-726.19), greater than Kazia Therapeutics Limited (-2.83), less than Titan Pharmaceuticals, Inc. (16.49), greater than Silo Pharma, Inc. (-1.25), greater than CNS Pharmaceuticals, Inc. (-0.20), greater than 60 Degrees Pharmaceuticals, Inc. (-0.31), greater than Xenetic Biosciences, Inc. (-3.28), greater than Qualigen Therapeutics, Inc. (-0.53), greater than Soligenix, Inc. (-0.40),

Build a custom stock screener for Calidi Biotherapeutics, Inc. (CLDI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Calidi Biotherapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Calidi Biotherapeutics, Inc. (CLDI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Calidi Biotherapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Calidi Biotherapeutics, Inc.'s PE Ratio?

How is the PE Ratio calculated for Calidi Biotherapeutics, Inc. (CLDI)?

What is the highest PE Ratio for Calidi Biotherapeutics, Inc. (CLDI)?

What is the 3-year average PE Ratio for Calidi Biotherapeutics, Inc. (CLDI)?

What is the 5-year average PE Ratio for Calidi Biotherapeutics, Inc. (CLDI)?

How does the current PE Ratio for Calidi Biotherapeutics, Inc. (CLDI) compare to its historical average?